These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 21668360)

  • 1. Relative contribution of HIV-specific functional lymphocyte subsets restricted by protective and non-protective HLA alleles.
    Peretz Y; Marra O; Thomas R; Legault D; Côté P; Boulassel MR; Rouleau D; Routy JP; Sékaly RP; Tsoukas CM; Tremblay C; Bernard NF
    Viral Immunol; 2011 Jun; 24(3):189-98. PubMed ID: 21668360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional T cell subsets contribute differentially to HIV peptide-specific responses within infected individuals: correlation of these functional T cell subsets with markers of disease progression.
    Peretz Y; Ndongala ML; Boulet S; Boulassel MR; Rouleau D; Côté P; Longpré D; Routy JP; Falutz J; Tremblay C; Tsoukas CM; Sékaly RP; Bernard NF
    Clin Immunol; 2007 Jul; 124(1):57-68. PubMed ID: 17521962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approaches.
    Tischer S; Dieks D; Sukdolak C; Bunse C; Figueiredo C; Immenschuh S; Borchers S; Stripecke R; Maecker-Kolhoff B; Blasczyk R; Eiz-Vesper B
    J Immunol Methods; 2014 Jun; 408():101-13. PubMed ID: 24877879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced Recognition of HIV-1 Cryptic Epitopes Restricted by HLA Class I Alleles Associated With a Favorable Clinical Outcome.
    Bansal A; Mann T; Sterrett S; Peng BJ; Bet A; Carlson JM; Goepfert PA
    J Acquir Immune Defic Syndr; 2015 Sep; 70(1):1-8. PubMed ID: 26322665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
    Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
    Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nef alleles from children with non-progressive HIV-1 infection modulate MHC-II expression more efficiently than those from rapid progressors.
    Schindler M; Wildum S; Casartelli N; Doria M; Kirchhoff F
    AIDS; 2007 May; 21(9):1103-7. PubMed ID: 17502720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of HLA-B57-restricted human immunodeficiency virus type 1 Gag- and RT-specific cytotoxic T lymphocyte responses.
    Klein MR; van der Burg SH; Hovenkamp E; Holwerda AM; Drijfhout JW; Melief CJ; Miedema F
    J Gen Virol; 1998 Sep; 79 ( Pt 9)():2191-201. PubMed ID: 9747728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of individual's T-cell immunome in controlling HIV-1 progression.
    Grifoni A; Montesano C; Palma P; Giovanetti M; Castelli-Gattinara G; Ciccozzi M; Mattei M; Mancino G; Salerno A; Colizzi V; Amicosante M
    Immunology; 2014 Dec; 143(4):631-9. PubMed ID: 24954875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective HLA Alleles Recruit Biased and Largely Similar Antigen-Specific T Cell Repertoires across Different Outcomes in HIV Infection.
    Koning D; Quakkelaar ED; Schellens IMM; Spierings E; van Baarle D
    J Immunol; 2022 Jan; 208(1):3-15. PubMed ID: 34880106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of HIV-specific CD8 T-cell responses among uninfected individuals exposed to HIV parenterally and mucosally.
    Makedonas G; Bruneau J; Alary M; Tsoukas CM; Lowndes CM; Lamothe F; Bernard NF
    AIDS; 2005 Feb; 19(3):251-9. PubMed ID: 15718835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-DR-restricted peptides identified in the Nef protein can induce HIV type 1-specific IL-2/IFN-gamma-secreting CD4+ and CD4+ /CD8+ T cells in humans after lipopeptide vaccination.
    Gahery H; Figueiredo S; Texier C; Pouvelle-Moratille S; Ourth L; Igea C; Surenaud M; Guillet JG; Maillere B
    AIDS Res Hum Retroviruses; 2007 Mar; 23(3):427-37. PubMed ID: 17411376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.
    Tan LC; Mowat AG; Fazou C; Rostron T; Roskell H; Dunbar PR; Tournay C; Romagné F; Peyrat MA; Houssaint E; Bonneville M; Rickinson AB; McMichael AJ; Callan MF
    Arthritis Res; 2000; 2(2):154-64. PubMed ID: 11062606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV Gag p24 specific responses secreting IFN-gamma and/or IL-2 in treatment-naïve individuals in acute infection early disease (AIED) are associated with low viral load.
    Ndongala ML; Peretz Y; Boulet S; Doroudchi M; Yassine-Diab B; Boulassel MR; Rouleau D; Tremblay C; LeBlanc R; Routy JP; Sékaly RP; Bernard NF
    Clin Immunol; 2009 May; 131(2):277-87. PubMed ID: 19135418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA Class I restricted CD8+ and Class II restricted CD4+ T cells are implicated in the pathogenesis of nevirapine hypersensitivity.
    Keane NM; Pavlos RK; McKinnon E; Lucas A; Rive C; Blyth CC; Dunn D; Lucas M; Mallal S; Phillips E
    AIDS; 2014 Aug; 28(13):1891-901. PubMed ID: 24911354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dual color ELISPOT method for the simultaneous detection of IL-2 and IFN-gamma HIV-specific immune responses.
    Boulet S; Ndongala ML; Peretz Y; Boisvert MP; Boulassel MR; Tremblay C; Routy JP; Sekaly RP; Bernard NF
    J Immunol Methods; 2007 Mar; 320(1-2):18-29. PubMed ID: 17222422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of HIV-1-derived cytotoxic T lymphocyte epitopes restricted by protective HLA-B alleles during the HIV-1 epidemic.
    Schellens IM; Navis M; van Deutekom HW; Boeser-Nunnink B; Berkhout B; Kootstra N; Miedema F; Keşmir C; Schuitemaker H; van Baarle D; Borghans JA
    AIDS; 2011 Sep; 25(14):1691-700. PubMed ID: 21681058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possession of human leucocyte antigen DQ6 alleles and the rate of CD4 T-cell decline in human immunodeficiency virus-1 infection.
    Vyakarnam A; Sidebottom D; Murad S; Underhill JA; Easterbrook PJ; Dalgleish AG; Peakman M
    Immunology; 2004 May; 112(1):136-42. PubMed ID: 15096192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immunodeficiency virus (HIV)-specific gamma interferon secretion directed against all expressed HIV genes: relationship to rate of CD4 decline.
    Peretz Y; Alter G; Boisvert MP; Hatzakis G; Tsoukas CM; Bernard NF
    J Virol; 2005 Apr; 79(8):4908-17. PubMed ID: 15795276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level.
    Moore CB; John M; James IR; Christiansen FT; Witt CS; Mallal SA
    Science; 2002 May; 296(5572):1439-43. PubMed ID: 12029127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory Killer Immunoglobulin-like Receptors to self HLA-B and HLA-C ligands contribute differentially to Natural Killer cell functional potential in HIV infected slow progressors.
    Kamya P; Tallon B; Melendez-Pena C; Parsons MS; Migueles SA; Connors M; Miconiatis S; Song R; Boulet S; Bruneau J; Tremblay CL; Bernard NF;
    Clin Immunol; 2012 Jun; 143(3):246-55. PubMed ID: 22445844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.